NIH-funded research Career grant

New ways to understand and treat sepsis-related blood vessel dysfunction

Official title: Novel Approaches to Identifying and Targeting Sepsis-Associated Endothelial Dysfunction

Funded at University of Wisconsin-Madison · NIH-11390478 · Data updated 2026-11-12

A doctor-scientist at a major university is researching how sepsis harms the lining of blood vessels and ways to detect or counteract it to prevent organ failure.

More Sepsis research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2029
Funding year2026
Award (this year)$187,410
NIH project number5K08GM160929-02
Project IDNIH-11390478 on NIH RePORTER

Who could benefit from this research

Could help

Patients with sepsis or at risk of sepsis-related organ dysfunction may benefit from advances stemming from this research.

Less likely to help

The study is primarily investigator training and foundational mechanistic work, so direct patient benefit may be limited during early stages.

What this research studies

This program supports a clinician-scientist to become an independent investigator focused on the mechanisms of sepsis-associated endothelial dysfunction. It uses two human-relevant approaches: a microphysiological system that mimics how sepsis in the blood affects the endothelium and a method to capture circulating endothelial cells from patients with sepsis for study. The goal is to uncover new pathways and potential targets for diagnosis and therapy while gaining advanced skills in endothelial injury techniques and transcriptomics. The 5-year plan combines coursework, hands-on research, and mentoring to build independent investigators who can translate findings into patient care.

Why it matters

Potential benefit: If successful, the work could lead to better diagnostic tools and targeted therapies to reduce organ failure and deaths from sepsis.

How similar studies have gone: Previous approaches using endothelial models and patient-derived cells have shown promise in identifying mechanisms and potential targets, but sepsis remains highly heterogeneous and translational challenges persist.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Faust, Hilary — University of Wisconsin-Madison
  • Study coordinator: Faust, Hilary

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.